alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MARCH 8, 2023

NO. 03-21-00422-CV

Billie 0. Stone d/b/a Stobil Enterprise, Appellant

v.

Randolph-Brooks Federal Credit Union, Appellee

APPEAL FROM THE 433RD DISTRICT COURT OF COMAL COUNTY

BEFORE JUSTICES BAKER, KELLY, AND SMITH

AFFIRMED -- OPINION BY JUSTICE BAKER

This is an appeal from the order dismissing the lawsuit signed by the trial court on July 20, 2021.

Having reviewed the record and the parties’ arguments, the Court holds that there was no 

reversible error in the order. Therefore, the Court affirms the trial court’s order dismissing the 

lawsuit. Appellant shall pay all costs relating to this appeal, both in this Court and in the court 

below.
§ 102-34.210 May I use a Government motor vehicle for transportation between places of employment and mass transit facilities? Yes, you may use a Government motor vehicle for transportation between places of employment and mass transit facilities under the following conditions: ( a ) The head of your agency must make a determination in writing, valid for one year, that such use is appropriate and consistent with sound budget policy, and the determination must be kept on file;
( b ) There is no safe and reliable commercial or duplicative Federal mass transportation service that serves the same route on a regular basis;
( c ) This transportation is made available, space provided, to other Federal employees;
( d ) Alternative fuel vehicles should be used to the maximum extent practicable;
( e ) This transportation should be provided in a manner that does not result in any additional gross income for Federal income tax purposes; and
( f ) Motor vehicle ridership levels must be frequently monitored to ensure cost/benefit of providing and maintaining this transportation.
EXHIBIT 32

                                  CERTIFICATION

     In  connection  with  the  Quarterly  Report  of  AMREP   Corporation  (the
"Company") on Form 10-Q for the period ending October 31, 2003 as filed with the
Securities and Exchange  Commission on the date hereof (the  "Report"),  each of
the  undersigned  does hereby  certify,  pursuant to 18 U.S.C.  Section 1350, as
adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that to the
best of his knowledge:

          (1) The Report fully complies with the  requirements  of section 13(a)
     or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information  contained in the Report fairly  presents,  in all
     material respects, the financial condition and results of operations of the
     Company.


Dated:  December 11, 2003

                                                 /s/ Peter M. Pizza
                                                 -----------------------
                                                 Peter M. Pizza
                                                 Chief Financial Officer

                                                 /s/ James Wall
                                                 -----------------------
                                                 James Wall*

                                                 /s/ Michael P. Duloc
                                                 -----------------------
                                                 Michael P. Duloc*

______________
*The  Registrant  is a  holding  company  which  does  substantially  all of its
business through two wholly-owned  subsidiaries (and their subsidiaries).  Those
wholly-owned  subsidiaries  are AMREP  Southwest  Inc.  ("ASW")  and Kable  News
Company,  Inc. ("Kable").  James Wall is the principal executive officer of ASW,
and Michael P. Duloc is the principal executive officer of Kable. The Registrant
has no chief executive  officer and its only executive  officers are James Wall,
Senior Vice  President and Peter M. Pizza,  Vice President and Michael P. Duloc,
who may be deemed an executive officer by reason of his position with Kable.
EXHIBIT 10.37



AGREEMENT FOR THE TRANSFER OF SPONSORS OBLIGATIONS



WHEREAS, Corautus Genetics Inc. (hereinafter CGI) corporation doing business at 75 Fifth Street, NW, Suite 313, Atlanta, GA
30308 has developed an article pVGI.1(VEGF2) which it wishes to test in clinical trials for myocardial ischemia (MI); and,



WHEREAS, CGI wishes to transfer some, but not all, of its legal obligations surrounding its objective of filing an Investigational New Drug Application (IND) for a drug
for MI under the Code of Federal Regulations (CFR) as they interpret the Food, Drug and Cosmetic Act (the Act); and,



WHEREAS, PPD Development, LP (hereinafter PPD) a Texas limited partnership with its principal place of business at Wilmington, North Carolina, does agree, for
a consideration as provided in the contract between CGI and PPD, to accept some, but not all, of CGIs responsibilities under the Act and provides notice that all obligations not explicitly transferred to PPD, or shared by CGI and PPD, remain
the responsibility of CGI;



NOW, THEREFORE, in consideration of the premises,
the parties hereby agree that the following responsibilities, upon execution of this document by the parties, be effectively transferred from CGI to PPD:



OBLIGATIONS UNDER 21 CFR PART 312 INVESTIGATIONAL NEW DRUG APPLICATION



1) reviewing and evaluating the evidence relating to the safety of the investigational drug as such evidence is obtained from the
investigator, as referenced in 21 CFR 312.56(c);



This agreement shall be
effective on the latter of the signature dates shown below.



In Witness
Whereof, the parties have executed this agreement or caused this Agreement to be executed by their duly authorized representatives in duplicate originals on the dates shown below.



|                       |  |                         |  |                     |  |                           
|---------------------- |  | ----------------------- |  | ------------------- |  | --------------------------
|Corautus Genetics Inc. |  | PPD Development, LP    
|                       |  |                        
|                       |  |                         |  | By: PPD GP, LLC    
|                       |  |                         |  | Its General Partner
|                       |  |                         | 
|By:                    |  | /s/ Richard E. Otto     |  | By:                 |  | /s/ Fred B. Davenport, Sr.
|Name:                  |  | Richard E. Otto         |  | Name:               |  | Fred B. Davenport, Sr.    
|Its:                   |  | Chief Executive Officer |  | Its:                |  | President                 
|Date:                  |  | March 7, 2005           |  | Date:               |  | March 7, 2005
**EXHIBIT 10.14**

 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIESACT”) OR ANY OTHER APPLICABLE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT, AND OTHER APPLICABLE SECURITIES LAWS. 

 

CORAUTUS GENETICS INC. 

 

and 

 

VASCULAR GENETICS INC. 

 

SENIOR CONVERTIBLE PROMISSORY NOTE 

 

 

No. 001 

 

FOR VALUE RECEIVED, each of the undersigned, Corautus Genetics Inc., aDelaware corporation (the “Parent”), and Vascular Genetics Inc., a Delaware corporation (“VGI” and, together with Parent, the “Issuers”), HEREBY JOINTLY AND SEVERALLY PROMISES TO PAY to the order ofBOSTON SCIENTIFIC CORPORATION (“BSC”) or its assigns (the “Holder”) the principal sum of U.S. $2,500,000, payable as provided herein, with the final payment of principal and accrued interest being due on the seventhanniversary of the date hereof (the “Final Maturity Date”). The Issuers may not prepay this Senior Convertible Promissory Note (this “Note”). 

 

This Note is one of the Notes referred to in the Loan Agreement among the Issuers and BSC, dated July 30, 2003 as amended bythe First Amendment to Loan Agreement dated December 29, 2003 (collectively, the “Loan Agreement”). 

 

Reference is made to, and this Note is subject to the further provisions set forth under, “Terms and Conditions of the Senior ConvertiblePromissory Note” attached hereto, with the same effect as though such further provisions were fully set forth at this place. 

IN WITNESS WHEREOF, the Issuers have caused this Note to be executed by their respective officersthereunto duly authorized, as of the date first above written. 

 

CORAUTUS GENETICS INC.

as Issuer

By
 
/s/ Richard E. Otto
  
Richard E. Otto

President & Chief Executive Officer

VASCULAR GENETICS INC.

as Issuer

By
 
/s/ Richard E. Otto
  
Richard E. Otto

President & Chief Executive Officer

 

2
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-28-1998
<PERIOD-START>                             MAR-29-1997
<PERIOD-END>                               MAR-28-1998
<CASH>                                           7,239
<SECURITIES>                                         0
<RECEIVABLES>                                   23,127
<ALLOWANCES>                                       240
<INVENTORY>                                     18,061
<CURRENT-ASSETS>                                49,114
<PP&E>                                          17,548
<DEPRECIATION>                                   8,593
<TOTAL-ASSETS>                                  58,806
<CURRENT-LIABILITIES>                           28,161
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        21,142
<OTHER-SE>                                       6,602
<TOTAL-LIABILITY-AND-EQUITY>                    58,806
<SALES>                                        112,685
<TOTAL-REVENUES>                               112,685
<CGS>                                          105,171
<TOTAL-COSTS>                                  111,640
<OTHER-EXPENSES>                                    30
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 209
<INCOME-PRETAX>                                  1,015
<INCOME-TAX>                                       386
<INCOME-CONTINUING>                                629
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       629
<EPS-PRIMARY>                                     0.07
<EPS-DILUTED>                                     0.07
        

</TABLE>
#### § 102-75.1010 When is a reviewing authority required to approve the determination concerning a property that is to be abandoned, destroyed, or donated?

A reviewing authority must approve determinations made under § 102-75.1000 before any such disposal, whenever all the property proposed to be disposed of by a Federal agency has a current estimated fair market value of more than $50,000.
March 25, 2014

Robert A. Wright

President

Wright Aviation Solutions, LLC

910 Harris Avenue Suite 401

Bellingham, WA 98225

Kent Ewing

President

Bonanza/Baron Pilot Training, Inc.

1509 Duke of Windsor Road

Virginia Beach, VA 23454

Dear Mr. Wright and Mr. Ewing:

This is in response to your January 27, 2014, letter sent to the public docket (No. FAA-2014-

0048) petitioning on behalf of Wright Aviation Solutions LLC (Wright Aviation) and 

Bonanza/Baron Pilot Training, Inc.(Bonanza/Baron). Your letter requests the Federal 

Aviation Administration revise Advisory Circular (AC) 61.91J “WINGS”- Pilot Proficiency

Program to enable expanded options under the FAA’s Pilot Proficiency Program, WINGS. 

Changes or amendments to advisory circulars are not processed in accordance with 14 CFR 

part 11. We have forwarded your request to the Flight Standards Service, General Aviation 

and Commercial Division (AFS-800) for review and response. 

Docket No. FAA-2014-0048 will be closed with no further action taken.

If you have any questions regarding this issue, please contact Valerie Palazzolo, Manager, 

FAA Safety Team (AFS-850) at (202) 385-9594.

Sincerely,

//s//

Brenda D. Courtney

Manager, Aircraft and 

 Airport Rules Division
§ 105-70.046 Compromise or settlement. ( a ) Parties may make offers of compromise or settlement at any time.
( b ) The reviewing official has the exclusive authority to compromise or settle a case under this part at any time after the date on which the reviewing official is permitted to issue a complaint and before the date on which the ALJ issues an initial decision.
( c ) The Authority Head has exclusive authority to compromise or settle a case under this part at any time after the date on which the ALJ issues an initial decision, except during the pendency of any review under § 105-70.042 or during the pendency of any action to collect penalties and assessments under § 105-70.043.
( d ) The Attorney General has exclusive authority to compromise or settle a case under this part during the pendency of any review under § 105-70.042 or of any action to recover penalties and assessments under 31 U.S.C. 3806.
( e ) The investigating official may recommend settlement terms to the reviewing official, the Authority Head, or the Attorney General, as appropriate. The reviewing official may recommend settlement terms to the Authority Head, or the Attorney General, as appropriate.
( f ) Any compromise or settlement must be in writing.
UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

ELBERT PARR TUTTLE COURT OF APPEALS BUILDING

56 Forsyth Street, N.W.

Atlanta, Georgia 30303

David J. Smith

Clerk of Court 

August 18, 2023

For rules and forms visit

www.ca11.uscourts.gov

MEMORANDUM TO COUNSEL OR PARTIES

Appeal Number: 23-12472-D

Case Style: GRACE, Inc., et al v. City of Miami

District Court Docket No: 1:22-cv-24066-KMM

All counsel must file documents electronically using the Electronic Case Files ("ECF") system, 

unless exempted for good cause. Although not required, non-incarcerated pro se parties are 

permitted to use the ECF system by registering for an account at www.pacer.gov. Information 

and training materials related to electronic filing are available on the Court's website.

Briefing

Pursuant to 11th Cir. R. 31-1, the appellant's brief is due on or before September 11, 2023. The 

appendix is due 7 days after the appellant's brief is filed. An incarcerated pro se party is not 

required to file an appendix. 

The appellee's brief is due within 30 days after the service of the last appellant's brief. The 

appellant's reply brief, if any, is due within 21 days after the service of the last appellee's brief. 

This is the only notice you will receive regarding the due date for briefs and appendices.

Please see FRAP 32(a) and the corresponding circuit rules for information on the form of briefs 

and FRAP 32(b) and 11th Cir. Rules 30-1 and 30-2 for information on the form of appendices.

This is the only notice you will receive concerning the due date for filing briefs and appendices.

See Fed.R.App.P. 28, 30, 31, 32, the corresponding circuit rules, General Order 39 and the 

Guide to Electronic Filing for further information. Pro se parties who are incarcerated are not 

required to file an appendix.

If you have not entered your appearance in this appeal, please note that the clerk may not 

process your filings. See 11th Cir. R. 46-6. Appearance of Counsel Forms are available on the 

court's Web site.

Attorneys must file briefs electronically using the ECF system. Use of ECF does not modify the 

requirements of the circuit rules that counsel must also provide four (4) paper copies of a brief 

USCA11 Case: 23-12472 Document: 30 Date Filed: 08/18/2023 Page: 1 of 2

Case 1:22-cv-24066-KMM Document 104-3 Entered on FLSD Docket 08/25/2023 Page 1 of 2
to the court, nor does it modify the requirements of the circuit rules for the filing of appendices 

in a particular case.

Clerk's Office Phone Numbers

General Information: 404-335-6100 Attorney Admissions: 404-335-6122

Case Administration: 404-335-6135 Capital Cases: 404-335-6200

CM/ECF Help Desk: 404-335-6125 Cases Set for Oral Argument: 404-335-6141

BR-1CIV Civil appeal briefing ntc issued

USCA11 Case: 23-12472 Document: 30 Date Filed: 08/18/2023 Page: 2 of 2

Case 1:22-cv-24066-KMM Document 104-3 Entered on FLSD Docket 08/25/2023 Page 2 of 2
Exhibit 32.1


Certification  of Principal Executive Officer and Principal Financial Officer
 Pursuant To 18 U.S.C. Section 1350,
 As Adopted Pursuant To
 Section 906 Of The Sarbanes-Oxley Act Of 2002
 
 
 In connection with the Yearly Report of Vantone International Group, Inc. (the "Company") on Form 10-K for the year ended March 31, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Honggang Yu, President, Chief Executive Officer and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 (1) The Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and
 
 (2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company.
 
  July 12, 2011
/s/ Honggang YuHonggang YuPresident,

Chief Executive Officer andChief Financial Officer

(Principal Executive Officer and Principal Financial Officer)
CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,
 AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the Annual Report of Humatech, Inc. (the "Company") on Form 10-KSB for the year ended April 30, 2003, as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, J.D. Rottweiler, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
 
 (1)  The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)  Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 Dated: December 8, 2003
/s/ J.D. RottweilerBy: J.D. RottweilerIts: Chief Financial Officer 
 
 A signed original of this written statement required by Section 906 has been provided to Humatech, Inc. and will be retained by Humatech, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 65, Number 121 (Thursday, June 22, 2000)]
[Notices]
[Page 38838]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15741]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel.
    Date: July 18, 2000.
    Time: 1 PM to 2 PM.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Henry J. Haigler, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National 
Institutes of Mental Health, NIH, Neuroscience Center, 6001 
Executive Blvd., Rm. 6150, MSC 9608, Bethesda, MD 20892-9608, 301/
443-7216.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel.
    Date: July 21, 2000.
    Time: 1 PM to 2 PM.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Henry J. Haigler, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Rm. 6150, MSC 9608, Bethesda, MD 20892-9608, 301/443-7216.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)


    Dated: June 14, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-15741 Filed 6-21-00; 8:45 am]
BILLING CODE 4140-01-M
#### § 105-74.660 Recipient.

*Recipient* means any individual, corporation, partnership, association, unit of government (except a Federal agency) or legal entity, however organized, that receives an award directly from a Federal agency.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5325 Introduced in House (IH)]

106th CONGRESS
  2d Session
                                H. R. 5325

To amend title 18, United States Code, to ensure that acts of torture, 
    as proscribed by the Torture Convention, are also recognized as 
              criminal if committed in the United States.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 27, 2000

  Ms. Waters introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend title 18, United States Code, to ensure that acts of torture, 
    as proscribed by the Torture Convention, are also recognized as 
              criminal if committed in the United States.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Torture Prevention and 
Accountability Act of 2000''.

SEC. 2. TORTURE IN THE UNITED STATES.

    Section 2340A of title 18, United States Code, is amended--
            (1) in subsection (a), by inserting ``or within'' after 
        ``outside'';
            (2) in subsection (b)--
                    (A) by striking ``or'' at the end of paragraph (1);
                    (B) by striking the period at the end of paragraph 
                (2) and inserting ``; or'' and
                    (C) by adding at the end the following:
            ``(3) the offense takes place in the United States.''; and
            (3) in subsection (a), by striking ``punished by death 
        or''.
                                 <all>
```